Taylor Ann Elizabeth

Taylor Ann Elizabeth is listed in filings as Director at Terns Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jul 2, 2024, including 2 public disclosures. Recent filings connect the profile to Terns Pharmaceuticals, Inc. (TERN). The current snapshot covers public activity from Jun 14, 2024 to Jul 2, 2024. Reported amounts are shown as $32.0K to $223.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.